Sleep apnea — a disorder in which one’s breathing is interrupted for seconds or minutes at a time during sleep — affects ...

The "Sleep Apnea Therapeutics Market View" report offers a detailed analysis of current and future competition, highlighting China's projected dominance in diagnosed cases by 2024 and 2029. It ...

Bad Boys director Michael Bay quits new Will Smith film over creative differences McDonald’s hash browns, with a side of ...

Snoring, a common issue, can disrupt sleep and signal underlying health problems like sleep apnea. Factors such as nasal ...

Nyxoah (Nasdaq:NYXH) announced today that it received FDA approval for its Genio neuromodulation device for treating sleep apnea.

Genio is a different approach to hypoglossal nerve stimulation (HGNS) for the treatment of OSA. Genio’s unique design ...

It affects millions of people in the UK, and can increase the risk of serious health problems like high blood pressure, heart ...

Nyxoah said the FDA approved the company's Genio system for a subset of patients with moderate to severe obstructive sleep apnea. The system includes a wearable component, which provides patients with ...

Left untreated, it can increase the risk of serious health problems like high blood pressure, heart disease, and diabetes ...

Left untreated, it can increase the risk of serious health problems like high blood pressure, heart disease, and diabetes ...

Investing.com -- Incannex Healthcare Inc. (NASDAQ: IXHL) stock jumped 10% Friday following the release of positive Phase 2 trial results for its obstructive sleep apnea (OSA) treatment, IHL-42X.

Yes, you just read that sleep deprivation can't kill you, except in the case of the rare genetic disease FFI. Although it's ...